Tisento Therapeutics has dosed the first subject in its Phase IIb PRIZM study, examining the effects of the oral ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatmentAlzheimer's disease progression does ...

Published pharmacokinetic data indicate accelerated renal clearance (CL) of vancomycin in obese patients, which would appear to justify a weight-based dosing regimen, with doses increasing as a ...

Novo Nordisk has reported topline outcomes from a Phase Ib/IIa trial of amycretin designed for treating obese or overweight ...

A novel use of a common treatment for opioid addiction might not be as effective as first believed, according to a recently ...

Following receipt of dupilumab for 24 weeks, desensitization to peanut exposure in most children/adolescents with peanut ...

Brachytherapy stands out as a highly effective treatment option for cases where the residual disease is detected, which ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Scientists reveal groundbreaking discoveries about probiotics and acne treatment. Learn how these tiny organisms could ...

An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

Six scientists from two universities in Malatya, eastern Türkiye, are developing a new treatment method to prevent pleuritis ...